Founded in 2008 and headquartered in Shanghai, HealthWell Nutrition (China) Co., Ltd. is a leading domestic enterprise focused on science-backed nutritional supplements and health management solutions. Rooted in China's dietary culture and public health demands, it has grown from a regional basic vitamin supplier to a national brand with full R&D, production, and omni-channel capabilities over 16 years. A key milestone in 2015 was establishing a state-level R&D center in Suzhou, which specializes in extracting active ingredients from Chinese herbs (e. g., wolfberry, ginseng) and combining them with modern nutrition science-differentiating it from global competitors. It also holds top certifications: GMP for food supplements, ISO 9001, and China's "Blue Hat Mark" for over 80% of its products.

In performance, HealthWell has grown steadily in China's health economy. From 2020 to 2024, its annual revenue had a 18.2% CAGR, hitting RMB 2.3 billion in 2024. It now holds 4.5% of China's nutraceutical market, ranking top 10 among private brands. Its market reach relies on a dual-channel network: Over 3, 000 offline partnerships with pharmacy chains (e. g., , ) and supermarkets, plus strong online sales-45% of total revenue comes from Tmall/JD flagship stores, with a 62% customer retention rate (well above the 40% industry average). Notably, its core products (children's probiotic powders, middle-aged women's collagen peptides) have ranked top 3 in their categories on major e-commerce platforms since 2022.

HealthWell's business covers three key segments:

Basic Nutrition: Age-specific daily supplements (multivitamins, calcium tablets, omega-3 fatty acids) for children, adolescents, and seniors.

Functional Health: Targeted products like immunity-boosting herbal extracts, liver-protective formulas, and sports nutrition (protein powders, electrolytes).

Customized Services: Personalized nutrition consulting via WeChat mini-program, offering tailored advice based on health assessments and one-on-one guidance from certified dietitians.

Looking forward, HealthWell is poised to leverage China's market trends. Driven by aging (20% of Chinese will be over 60 by 2030), post-pandemic health awareness, and "Healthy China 2030" policy, the domestic nutraceutical market is expected to reach RMB 1.2 trillion by 2028. To seize this, the company plans to: (1) Increase R&D investment by 25% yearly to develop products for underserved groups (senior gut health, high-risk prenatal nutrition); (2) Deepen digital transformation with an AI-powered health APP; (3) Explore Southeast Asian markets (Singapore, Malaysia) where Chinese herbal supplements are in demand. With a focus on quality, localization, and consumer-centric innovation, HealthWell aims to become a global leader in integrating Chinese health wisdom and modern nutrition by 2035.